Comparison of outcome measures during treatment with the proprietary Harpagophytum extract Doloteffin® in patients with pain in the lower back, knee or hip

This publication has 34 references indexed in Scilit:

• Doloteffin® vs. Vioxx® for low back pain – a randomised double‐blind pilot study
  Focus on Alternative and Complementary Therapies, 2002
• Treating low back pain with an extract of Harpagophytum that inhibits cytokine release
  European Journal of Anaesthesiology, 2002
• Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain:An open non-randomized study
  Phytomedicine, 2001
• Generic and condition-specific outcome measures for people with osteoarthritis of the knee
  Rheumatology, 1999
• Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind study
  European Journal of Anaesthesiology, 1999
• A survey on pain complaints and health care utilization in a German population sample
  European Journal of Anaesthesiology, 1998
• Wirksamkeit und Wirtschaftlichkeit von Teufelskrallenwurzelextrakt bei Rückenschmerzen: Erste Ergebnisse einer therapeutischen Kohortenstudie
  Complementary Medicine Research, 1997
• Low Back Pain Rating scale: validation of a tool for assessment of low back pain
  Pain, 1994
• The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip
  Arthritis & Rheumatism, 1991
• Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
  Arthritis & Rheumatism, 1986